These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6753140)

  • 1. Biological monitoring in the identification of the cancer of individuals exposed to chemical carcinogens.
    Vainio H; Sorsa M; Rantanen J; Hemminki K; Aitio A
    Scand J Work Environ Health; 1981 Dec; 7(4):241-51. PubMed ID: 6753140
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of various methodologies with respect to specificity and sensitivity in biomonitoring occupational exposure to mutagens and carcinogens.
    Lohman PH; Jansen JD; Baan RA
    IARC Sci Publ; 1984; (59):259-77. PubMed ID: 6545282
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of cytogenetic methods for biological monitoring.
    Vainio H; Sorsa M
    Annu Rev Public Health; 1983; 4():403-7. PubMed ID: 6860449
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic toxicology--relevant studies with animals and humans.
    Legator MS; Ward JB
    Prog Clin Biol Res; 1984; 160():491-525. PubMed ID: 6382338
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the levels of chromosome aberration and sister chromatid exchange induced by chemical mutagens in vitro].
    Shcheglova EG; Chebotarev AN
    Biull Eksp Biol Med; 1983 Nov; 96(11):93-5. PubMed ID: 6416331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological monitoring of exposure to carcinogens].
    Vainio H; Sorsa M; Rantanen J; Hemminki K; Aitio A
    Duodecim; 1981; 97(15):1141-52. PubMed ID: 7327105
    [No Abstract]   [Full Text] [Related]  

  • 7. Sister chromatid exchanges induced by cancer chemotherapeutic agents in vitro and in vivo: consideration of the hazard of drugs as possible mutagens and carcinogens causing second malignancies.
    Abe T; Tsuda S; Maekawa T; Taniwaki M; Sonoda Y; Ide T; Misawa S; Takino T; Inoue K
    Cancer Treat Rep; 1985 May; 69(5):505-14. PubMed ID: 4005873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of carcinogens and mutagens as alkylating agents following chemical activation.
    Archer MC; Eng VW
    Chem Biol Interact; 1981 Jan; 33(2-3):207-14. PubMed ID: 7460066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic methods in the detection of chemical carcinogens.
    Sorsa M
    J Toxicol Environ Health; 1980; 6(5-6):1077-80. PubMed ID: 7463503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange.
    Perry P; Evans HJ
    Nature; 1975 Nov; 258(5531):121-5. PubMed ID: 52847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of chromosomal aberrations and sister chromatid exchanges by propane sultone in human lymphocytes in vitro.
    Kaul BL
    Toxicol Lett; 1985 Nov; 28(2-3):139-42. PubMed ID: 4071562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of the sister chromatid exchange level with chromosome aberrations induced by chemical mutagens in vivo].
    Shcheglova EG; Chebotarev AN
    Biull Eksp Biol Med; 1983 Dec; 96(12):67-9. PubMed ID: 6419793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sister chromatid exchange in cancer.
    Kohn PH
    Ann Clin Lab Sci; 1983; 13(4):267-74. PubMed ID: 6354062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological monitoring in surveillance of exposure to genotoxicants.
    Vainio H; Sorsa M; Hemminki K
    Am J Ind Med; 1983; 4(1-2):87-103. PubMed ID: 6340486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of mutagenicity tests in assessing occupational genotoxic risks.
    Vainio H; Sorsa M
    Prog Clin Biol Res; 1982; 109():433-42. PubMed ID: 7167555
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the level of sister chromatid exchanges and chromosome aberrations induced by chemical mutagens in vitro and in vivo].
    Shcheglova EG; Chebotarev AN
    Tsitol Genet; 1985; 19(1):20-3. PubMed ID: 3992652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome aberrations and sister-chromatid exchange frequencies in pathology staff occupationally exposed to formaldehyde.
    Thomson EJ; Shackleton S; Harrington JM
    Mutat Res; 1984 Oct; 141(2):89-93. PubMed ID: 6493271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative effectiveness in the induction of sister chromatid exchanges and chromosome aberrations].
    Shcheglova EG; Chebotarev AN
    Tsitol Genet; 1984; 18(5):364-8. PubMed ID: 6506217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer chemotherapy and the development of secondary leukemia.
    Abe T; Misawa S
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1843-56. PubMed ID: 3836550
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of chemical carcinogenicity from in vitro genetic toxicity.
    Heddle JA
    Mutagenesis; 1988 Jul; 3(4):287-91. PubMed ID: 3062315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.